GGrantIndex
Sort

21,453 grants matching tuberculosis

Mycobacterium tuberculosis evasion of CD4+ T cells in vivo

$413,507
Joel D. Ernst · New York University School Of Medicine · R01 · FY2010 · AI

Assessing Social Justice in Economic Evaluation to Scale up Novel MDR-TB Regimens

$413,463
Maria Weston Merritt · Johns Hopkins University · R01 · FY2016 · AI

Biogenesis of lipoarabinomannan in mycobacteria

$413,416
Mary Jackson · Colorado State University · R01 · FY2012 · AI

PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY

$413,273
Peterjohn Diaz Camacho · Guam Department Of Public Health-Soc Svc · U52 · FY2009 · PS

PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY

$413,273
Peterjohn Diaz Camacho · Guam Department Of Public Health-Soc Svc · U52 · FY2008 · PS

Role of lipid mediators in host resistance to Mycobacterium tuberculosis

$413,236
Heinz Gernot Remold · Brigham And Women'S Hospital · R01 · FY2007 · AI

Vulnerabilities in Mycobacterial Cell-Wall Biogenesis

$413,235
Thomas C Alber · Texas A&M University · P01 · FY2014 · AI

Molecular Genetic Analysis of Mycobacterium tuberculosis

$413,135
Albert Einstein Col Of Med Yeshiva Univ · R37 · FY2005 · AI

Fixed E. coli as Low Range Nucleic Acid Controls for M. tuberculosis Testing

$413,123
Clark A. Rundell · Maine Molecular Quality Controls, Inc. · R44 · FY2006 · AI

Four Mtb Membrane Proteins: Structure and Function

$413,113
Timothy A Cross · Florida State University · R01 · FY2009 · AI

Identifying a protective role for interferon lambda in tuberculosis

$413,002
Joshua T. Mattila · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · AI

Synthetic Ligands for Modulating Immune Cell Responses

$412,845
Laura L Kiessling · Massachusetts Institute Of Technology · R01 · FY2017 · AI

Chemical Mycobacteriology

$412,787
Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2013 · AI

Cell Surface Receptors on T cells and Macrophages

$412,757
Cornelis P Terhorst · Beth Israel Deaconess Medical Center · R01 · FY2010 · AI

A strategy for new regimens to treat pulmonary Mycobacteroides abscessus infection

$412,731
Gyanu Lamichhane · Johns Hopkins University · R01 · FY2020 · AI

Mechanisms of Impaired Mycobacteria Sensing by TLR2 and TLR4 Polymorphic Variants

$412,702
Andrei E Medvedev · University Of Connecticut Sch Of Med/Dnt · R56 · FY2014 · AI

US-Brazil Research Collaboration on Strain Variation in TB

$412,646
Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2005 · AI

Drug resistance in tuberculosis: genetic and dynamics

$412,590
Harvard University (Sch Of Public Hlth) · R01 · FY2002 · AI

Remodeling of the M. tuberculosis cell wall during infection

$412,575
David Branch Moody · Brigham And Women'S Hospital · R01 · FY2010 · AI

T-Cell response to CD1-restricted lipids in Tuberculosis

$412,575
David Branch Moody · Brigham And Women'S Hospital · R01 · FY2010 · AI

Type I Interferons in Immunity to Tuberculosis

$412,571
Joel D. Ernst · New York University School Of Medicine · R01 · FY2006 · AI

Activation of latent TGF-beta by integrins

$412,571
John S. Munger · New York University School Of Medicine · R01 · FY2006 · HL

Characterization of Mycobacterial Sigma Factors

$412,509
Robert N Husson · Boston Children'S Hospital · R01 · FY2010 · AI

Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection

$412,506
Riti Sharan · Texas Biomedical Research Institute · R21 · FY2022 · AI

Geobiological approaches to understanding pulmonary infections in situ

$412,500
Dianne K Newman · California Institute Of Technology · R01 · FY2012 · HL